Drugs Safety Labeling Updates
Drugs Safety Labeling Updates
| Scientific Name | Trade Name | Updated Section | Safety-Related Labeling Changes | Date |
|---|---|---|---|---|
| Paroxetine | Seroxat | 4.8 Undesirable effects | Leukopenia | Oct,2023 |
| Insulin Degludec,Liraglutide | Xultophy | 4.8 Undesirable effects | Acute pancreatitis, hemorrhagic and necrotizing pancreatitis sometimes resulting in death | Jul, 2024 |
| Liraglutide | Victoza | 4.8. Undesirable effects | Ileus, Dysgeusia | Jun, 2024 |
| Cabozantinib | Cometriq | 4.8 Undesirable effects | Embolism arterial | Oct,2023 |
| Semaglutide | Rybelsus | 4.4 Special Warnings and Special Precautions for Use | Acute Gallbladder Disease | Apr,2024 |
| Insulin Glargine; Lixisenatide | Soliqua Solostar | "4.6. Fertility, pregnancy and lactation " | Contraindicated use in women of childbearing potential not using contraception | Jul, 2024 |